Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1994 Jul 16;309(6948):175–179. doi: 10.1136/bmj.309.6948.175

Diffuse lung disease: an approach to management.

R M du Bois 1
PMCID: PMC2540701  PMID: 8044098

Full text

PDF
175

Images in this article

178FIG 2
on p.178
178FIG 3
on p.178

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gilman M. J., Wang K. P. Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis. 1980 Nov;122(5):721–724. doi: 10.1164/arrd.1980.122.5.721. [DOI] [PubMed] [Google Scholar]
  2. Hansell D. M., Kerr I. H. The role of high resolution computed tomography in the diagnosis of interstitial lung disease. Thorax. 1991 Feb;46(2):77–84. doi: 10.1136/thx.46.2.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Johnson M. A., Kwan S., Snell N. J., Nunn A. J., Darbyshire J. H., Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax. 1989 Apr;44(4):280–288. doi: 10.1136/thx.44.4.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Johnston I. D., Gomm S. A., Kalra S., Woodcock A. A., Evans C. C., Hind C. R. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. Eur Respir J. 1993 Jun;6(6):891–893. [PubMed] [Google Scholar]
  5. Johnston I., Britton J., Kinnear W., Logan R. Rising mortality from cryptogenic fibrosing alveolitis. BMJ. 1990 Nov 3;301(6759):1017–1021. doi: 10.1136/bmj.301.6759.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mathieson J. R., Mayo J. R., Staples C. A., Müller N. L. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology. 1989 Apr;171(1):111–116. doi: 10.1148/radiology.171.1.2928513. [DOI] [PubMed] [Google Scholar]
  7. Müller N. L. Clinical value of high-resolution CT in chronic diffuse lung disease. AJR Am J Roentgenol. 1991 Dec;157(6):1163–1170. doi: 10.2214/ajr.157.6.1950859. [DOI] [PubMed] [Google Scholar]
  8. Müller N. L., Miller R. R. Computed tomography of chronic diffuse infiltrative lung disease. Part 1. Am Rev Respir Dis. 1990 Nov;142(5):1206–1215. doi: 10.1164/ajrccm/142.5.1206. [DOI] [PubMed] [Google Scholar]
  9. Müller N. L., Miller R. R. Computed tomography of chronic diffuse infiltrative lung disease. Part 2. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1440–1448. doi: 10.1164/ajrccm/142.6_Pt_1.1440. [DOI] [PubMed] [Google Scholar]
  10. Müller N. L., Staples C. A., Miller R. R., Vedal S., Thurlbeck W. M., Ostrow D. N. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology. 1987 Dec;165(3):731–734. doi: 10.1148/radiology.165.3.3685351. [DOI] [PubMed] [Google Scholar]
  11. Tanner R. L. Mammographic unit compression force: acceptance test and quality control protocols. Radiology. 1992 Jul;184(1):45–48. doi: 10.1148/radiology.184.1.1609101. [DOI] [PubMed] [Google Scholar]
  12. Tukiainen P., Taskinen E., Holsti P., Korhola O., Valle M. Prognosis of cryptogenic fibrosing alveolitis. Thorax. 1983 May;38(5):349–355. doi: 10.1136/thx.38.5.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tung K. T., Wells A. U., Rubens M. B., Kirk J. M., du Bois R. M., Hansell D. M. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax. 1993 Apr;48(4):334–338. doi: 10.1136/thx.48.4.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980 Mar;35(3):171–180. doi: 10.1136/thx.35.3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax. 1980 Aug;35(8):593–599. doi: 10.1136/thx.35.8.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Turner-Warwick M., Haslam P. L. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis. 1987 Jan;135(1):26–34. doi: 10.1164/arrd.1987.135.1.26. [DOI] [PubMed] [Google Scholar]
  17. Venn G. E., Kay P. H., Midwood C. J., Goldstraw P. Open lung biopsy in patients with diffuse pulmonary shadowing. Thorax. 1985 Dec;40(12):931–935. doi: 10.1136/thx.40.12.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Weinberger S. E., Kelman J. A., Elson N. A., Young R. C., Jr, Reynolds H. Y., Fulmer J. D., Crystal R. G. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med. 1978 Oct;89(4):459–466. doi: 10.7326/0003-4819-89-4-459. [DOI] [PubMed] [Google Scholar]
  19. Wells A. U., Hansell D. M., Corrin B., Harrison N. K., Goldstraw P., Black C. M., du Bois R. M. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax. 1992 Sep;47(9):738–742. doi: 10.1136/thx.47.9.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wells A. U., Hansell D. M., Harrison N. K., Lawrence R., Black C. M., du Bois R. M. Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J. 1993 Jun;6(6):797–802. [PubMed] [Google Scholar]
  21. Wells A. U., Hansell D. M., Rubens M. B., Cullinan P., Black C. M., du Bois R. M. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1076–1082. doi: 10.1164/ajrccm/148.4_Pt_1.1076. [DOI] [PubMed] [Google Scholar]
  22. Wells A. U., Rubens M. B., du Bois R. M., Hansell D. M. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol. 1993 Dec;161(6):1159–1165. doi: 10.2214/ajr.161.6.8249719. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES